|
Oct 17
|
Autolus Therapeutics (AUTL): High-Growth UK Stock in Cancer Therapy
|
|
Oct 16
|
Autolus Therapeutics Presents Clinical Data Update at the 2024 Lymphoma, Leukemia & Myeloma Congress
|
|
Oct 16
|
Why Autolus Therapeutics plc (AUTL) is the Penny Stock with the Biggest Upside Potential According to Analysts
|
|
Oct 9
|
Autolus Therapeutics PLC (AUTL) Q2 2024 Earnings Call Highlights: Strategic Advances Amid ...
|
|
Jul 26
|
Autolus Therapeutics to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
|
|
May 31
|
Autolus Therapeutics presents longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL in an oral presentation at ASCO
|
|
May 18
|
Q1 2024 Autolus Therapeutics PLC Earnings Call
|
|
May 17
|
Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
|
|
May 14
|
Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress
|
|
May 13
|
Autolus Therapeutics Announces Delay to its First Quarter 2024 Earnings Release and Conference Call
|
|
Apr 25
|
Recent 13% pullback isn't enough to hurt long-term Autolus Therapeutics (NASDAQ:AUTL) shareholders, they're still up 157% over 1 year
|
|
Apr 24
|
Abstract for longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL selected for an oral presentation at ASCO
|
|
Apr 23
|
Autolus Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
|
|
Apr 2
|
Autolus Therapeutics announces acceptance of Marketing Authorization Application (MAA) by the European Medicines Agency (EMA) for obecabtagene autoleucel (obe-cel) for Patients with Relapsed/refractory (r/r) Adult B-Cell Acute Lymphoblastic Leukemia (B...
|
|
Mar 21
|
Q4 2023 BioNTech SE Earnings Call
|
|
Mar 17
|
Autolus Therapeutics plc (NASDAQ:AUTL) Q4 2023 Earnings Call Transcript
|
|
Mar 15
|
Autolus Therapeutics Full Year 2023 Earnings: EPS Misses Expectations
|
|
Mar 15
|
Q4 2023 Autolus Therapeutics PLC Earnings Call
|
|
Mar 14
|
Autolus Therapeutics PLC Reports Full Year 2023 Financial Results
|
|
Mar 14
|
Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates
|